Indication and Usage RYBELSUS (semaglutide) tablets 7 mg or 14 mg is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events Important Safety Information for RYBELSUS WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
(PubMed) Vahdaninia M, Mackenzie H, Dean T, Helps S
Two cases involved cholelithiasis, and two patients received treatment with either empagliflozin or sitagliptin, which could potentially contribute to or confound pancreatitis
There is no single number that applies to every patient
When youre not hungry, you dont eat
Here are examples of companies creating GLP-1 support frameworks: Wisp + Nourish: Wisp partnered with Nourish to bring dietitian support into telehealth-based weight care programs